Table 1.
Baseline demographic and biochemical parameters of studied patients
| Placebo | Cabergoline | p-value | 95% CI | |
|---|---|---|---|---|
| Sex (M/F) | 4/7 | 7/5 | 0.29 | |
| Age (y) | 51.18 ± 2.81 | 56.66 ± 2.23 | 0.139 | -12.89 — 1.92 |
| BMI (Kg/m2)a | 27.50 ± 1.21 | 30.67 ± 1.54 | 0.56 | -7.29 — 0.98 |
| FPG (mg/dl)b | 102.90 ± 2.61 | 106.25 ± 2.33 | 0.35 | -10.62 — 3.93 |
| OGTT (mg/dl) | 110.09 ± 11.41 | 143.25 ± 13.10 | 0.59 | -69.59 — 3.27 |
| A1c (%)c | 5.70 ± 0.08 | 5.70 ± 0.13 | 0.99 | -0.33 — 0.34 |
| Prolactin (ng/mL) | 9.65 ± 0.87 | 10.23 ± 1.86 | 0.09 | -5.03 — 3.79 |
Values represent as mean ± SEM
a
: Body Mass Index
b
: Plasma glucose of 2 hour after OGTT
c
: Glycated Hemoglobin A1c